Global Reports

Mithridatism: After the trade recession, exporters are more optimistic in 2024 but also more concerned with (and also more used to?) geopolitical risks, shortages of inputs and labor and financing and non-payment risks.

With its real estate and foreign investment engines sputtering, China desperately needs new drivers of growth.

Explore the stream of challenges to global trade in 2024 and see the tips for turning the trade challenges into export success.

Advantage running out and penalties looming: Most countries are seeing double-digit rebounds in business insolvencies as excess cash dwindles, leaving the most vulnerable corporates caught between a rock and a hard place in 2023.

The pharmaceutical industry is cooking up a storm, with weight-loss drugs serving as the main course. Diabetes and obesity have become the star ingredients driving the sector’s expansion, sidelining traditional staples like oncology and immunology.